Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimization of PK/PD Target Attainment for Meropenem in Critically Ill Patients With Sepsis

NCT03560557 is registered in ClinicalTrials.gov with Universitaire Ziekenhuizen KU Leuven as lead sponsor.

NCT NCT03560557
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03560557 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimization of PK/PD Target Attainment for Meropenem in Critically Ill Patients With Sepsis
Lead sponsor
Universitaire Ziekenhuizen KU Leuven
Phase
Observational
Overall status
Completed
Start date
August 31, 2012
Completion date
October 31, 2017
Enrollment
116 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

critical illness, pharmacokinetics